Menopause, Weight, and the GLP-1 Question

If you are in your forties or fifties and the things that used to keep your weight steady have quietly stopped working, you are not imagining it. Around half of women gain weight during the menopause transition, and it tends to settle around the middle in a way it never did before. This is not a willpower problem. It is a biology problem, and it deserves a proper answer rather than another lecture about eating less.

Why the rules change

As oestrogen falls, three things happen at once. Fat storage shifts from the hips and thighs towards the abdomen, including the deeper visceral fat that sits around your organs and drives inflammation. Muscle loss, which speeds up naturally after 40, accelerates further, and less muscle means a slower metabolism. Broken sleep and higher stress push cortisol up, which encourages the body to hold on to belly fat. Doing exactly what worked at 30 stops working, because the body you are doing it in has changed.

Do GLP-1 medicines still work after menopause?

Yes. GLP-1 treatments such as Wegovy and Mounjaro reduce appetite and help lower visceral fat. The evidence suggests they work just as well through and after the menopause transition, with no meaningful drop in response. What they do not do is treat menopause itself. They do not replace oestrogen or ease hot flushes. They are a tool for the weight and metabolic side of the picture, not a hormone therapy.

The two things you must protect: muscle and bone

This is the part that matters most at midlife, and the part the adverts skip. When you lose weight, some of what you lose is muscle, whatever method you use. At menopause you are already losing muscle and bone faster because of falling oestrogen, so losing more of either is the last thing you want. Weaker muscle and thinner bone raise the risk of frailty and fractures in later life.

It is worth being balanced. Some experts think the muscle-loss alarm has been overblown, and that most of what is lost is the natural result of no longer carrying the extra weight. The sensible position sits between the two camps. Do not panic, but do protect your muscle and bone on purpose.

The exercise that works at midlife

The advice that served you at 30, more cardio and longer runs, is not the advice that serves you now. Long bouts of hard cardio can raise cortisol and slow recovery, which at midlife can work against you. This does not mean movement is bad. It means the mix should change. The priority becomes protecting muscle and bone, with moderate and sustainable movement rather than punishing sessions:

• Strength training two to three times a week. Weights, resistance bands or bodyweight work. This is the single most important lever. It builds and protects muscle, keeps bone strong and steadies blood sugar. It does not need to be heavy or long to count.
• A moderate walk of 30 to 45 minutes on most days. Enough to lift your breathing, not to exhaust you. It supports fat loss, lowers inflammation and improves mood, without the cortisol load of relentless cardio.
• Protein at every meal. Around 1.2 to 1.6 grams per kilogram of body weight a day, with 25 to 30 grams at a time. Muscle cannot rebuild without it.
• Recovery and sleep. Muscle is built while you rest, and poor sleep raises the cortisol that drives belly fat.

Together, strength work and steady walking do what a menopausal body responds to. They lower inflammation, protect muscle and bone, and support fat loss, whether or not you are also on medication. Lose at a sensible pace too, because rapid loss raises the risk of muscle loss, gallstones and hair shedding.

If you take HRT, read this

Many women use hormone therapy through menopause, and many are also on a GLP-1. Two things are worth knowing. First, some studies suggest women on both lose more weight than on the GLP-1 alone. Those studies are observational, though, so they show an association, not proof of cause. Whether HRT is right for you is a decision for your GP or a menopause specialist, based on your symptoms and history. It is not something to start for weight loss alone.

Second, and this is the practical one, the type of GLP-1 and the form of HRT can matter. These medicines slow the stomach, which can affect how well tablets are absorbed. The clearest evidence is with oral contraceptives. Tirzepatide, the medicine in Mounjaro, has been shown to reduce their absorption by around a fifth after the first dose. Semaglutide, the medicine in Wegovy, does not. That evidence is about contraceptives rather than HRT, but the mechanism is the same. So if you take oral HRT alongside Mounjaro, ask your prescriber whether your dose or timing needs a look. Transdermal HRT, meaning patches, gels or sprays, bypasses the stomach entirely, so the question does not arise.